Researcher profile

Edmund Ellsworth

Edmund Ellsworth contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2022arXiv

Machine learning analysis of cocaine addiction informed by DAT, SERT, and NET-based interactome networks

Cocaine addiction is a psychosocial disorder induced by the chronic use of cocaine and causes a large of number deaths around the world. Despite many decades' effort, no drugs have been approved by the Food and Drug Administration (FDA) for the treatment of cocaine dependence. Cocaine dependence is neurological and involves many interacting proteins in the interactome. Among them, dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) are three major targets. Each of these targets has a large protein-protein interaction (PPI) network which must be considered in the anti-cocaine addiction drug discovery. This work presents DAT, SERT, and NET interactome network-informed machine learning/deep learning (ML/DL) studies of cocaine addiction. We collect and analyze 61 protein targets out 460 proteins in the DAT, SERT, and NET PPI networks that have sufficient existing inhibitor datasets. Utilizing autoencoder and other ML algorithms, we build ML/DL models for these targets with 115,407 inhibitors to predict drug repurposing potentials and possible side effects. We further screen their absorption, distribution, metabolism, and excretion, and toxicity (ADMET) properties to search for nearly optimal leads for anti-cocaine addiction. Our approach sets up a systematic protocol for artificial intelligence (AI)-based anti-cocaine addiction lead discovery.